Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Norursodeoxycholic acid

EU orphan designation number: EU/3/14/1288   
Active ingredient: Norursodeoxycholic acid
Indication: Treatment of primary sclerosing cholangitis
Sponsor: Dr Falk Pharma GmbH
Leinenweberstrasse 5, D-79108 Freiburg im Breisgau, Deutschland

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page
Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
08/07/2014 Orphan designation EMA/OD/026/14 (2014)4844 of 04/07/2014